Daniel Lightwood's Biography

Daniel Lightwood, Director, UCB Pharma

After studying for a PhD from the University of Cambridge, Biochemistry Department in the area of protein engineering, Dr Daniel Lightwood joined Celltech (acquired by UCB in 2004) in 1999. During his 16 years at UCB Celltech, Dr. Lightwood has played a key role in developing UCB’s Core antibody discovery platform and has been responsible for successfully applying the technology across a number of UCB therapeutic antibody programs. Dr. Lightwood currently holds the position of Director, Antibody Discovery at UCB Celltech managing the Core Antibody Discovery team.